Elastrin Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$500K
- Investors
-
6
Elastrin General Information
Description
Developer of antibody-targeted nanoparticle therapies designed to reverse arterial calcification and restore tissue elasticity. The company utilizes a proprietary platform to deliver active agents directly to damaged elastin fibers, providing targeted chelation and dual-targeted therapies, enabling healthcare sectors to reverse vascular hardening, improve blood flow, and eliminate the burden of cardiovascular disease without systemic side effects.
Contact Information
Website
www.elastrin.comCorporate Office
- 200 C, Patewood Drive
- Greenville, SC 29615
- United States
Corporate Office
- 200 C, Patewood Drive
- Greenville, SC 29615
- United States
Elastrin Timeline
Elastrin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 11-Mar-2025 | $500K | Completed | Pre-Clinical Trials | ||
| 8. Later Stage VC | 03-Nov-2023 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC | 08-Apr-2022 | Completed | Pre-Clinical Trials | |||
| 6. Seed Round | 04-Mar-2021 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Aug-2019 | Completed | Pre-Clinical Trials | |||
| 4. Grant | Completed | Pre-Clinical Trials | ||||
| 3. Grant | 13-Jan-2019 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 17-Nov-2018 | $25K | $25K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Elastrin Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 | ||||||||
| Seed | 550,000 | $0.001000 | $4.55 | $4.55 | 1x | $4.55 | 12.04% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Elastrin Comparisons
Industry
Financing
Details
Elastrin Competitors (3)
One of Elastrin’s 3 competitors is Cyclarity Therapeutics, a Venture Capital-Backed company based in Novato, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cyclarity Therapeutics | Venture Capital-Backed | Novato, CA | ||||
| Inozyme Pharma | Formerly VC-backed | Boston, MA | ||||
| Nectero Therapeutics | Venture Capital-Backed | Tempe, AZ |
Elastrin Signals
Elastrin Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Starbloom Capital | Venture Capital | Minority | ||
| Kizoo Technology Capital | Venture Capital | Minority | ||
| National Heart, Lung, and Blood Institute | Government | |||
| SC Launch | Venture Capital | Minority | ||
| Clemson University | University |
Elastrin FAQs
-
When was Elastrin founded?
Elastrin was founded in 2017.
-
Where is Elastrin headquartered?
Elastrin is headquartered in Greenville, SC.
-
What is the size of Elastrin?
Elastrin has 6 total employees.
-
What industry is Elastrin in?
Elastrin’s primary industry is Biotechnology.
-
Is Elastrin a private or public company?
Elastrin is a Private company.
-
What is Elastrin’s current revenue?
The current revenue for Elastrin is .
-
How much funding has Elastrin raised over time?
Elastrin has raised $20.2M.
-
Who are Elastrin’s investors?
Starbloom Capital, Kizoo Technology Capital, National Heart, Lung, and Blood Institute, SC Launch, and Clemson University are 5 of 6 investors who have invested in Elastrin.
-
Who are Elastrin’s competitors?
Cyclarity Therapeutics, Inozyme Pharma, and Nectero Therapeutics are competitors of Elastrin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process